These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31823620)

  • 21. Mental health and cognitive function responses to quetiapine in patients with methamphetamine abuse under methadone maintenance treatment.
    Javdan NS; Ghoreishi FS; Sehat M; Ghaderi A; Banafshe HR
    J Affect Disord; 2019 May; 251():235-241. PubMed ID: 30928863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anxiety reduction on atomoxetine and methylphenidate medication in children with ADHD.
    Snircova E; Marcincakova-Husarova V; Hrtanek I; Kulhan T; Ondrejka I; Nosalova G
    Pediatr Int; 2016 Jun; 58(6):476-81. PubMed ID: 26579704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder.
    Lee SI; Song DH; Shin DW; Kim JH; Lee YS; Hwang JW; Park TW; Yook KH; Lee JI; Bahn GH; Hirata Y; Goto T; Takita Y; Takahashi M; Lee S; Treuer T
    Asia Pac Psychiatry; 2014 Dec; 6(4):386-96. PubMed ID: 25345739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of patients with methamphetamine dependence with cue-elicited heart rate variability in a virtual social environment.
    Wang YG; Shen ZH; Wu XC
    Psychiatry Res; 2018 Dec; 270():382-388. PubMed ID: 30300868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the environmental enrichment on the severity of psychological dependence and voluntary methamphetamine consumption in methamphetamine withdrawn rats.
    Hajheidari S; Miladi-Gorji H; Bigdeli I
    Neurosci Lett; 2015 Jan; 584():151-5. PubMed ID: 25459292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.
    Nawata Y; Kitaichi K; Yamamoto T
    Drug Alcohol Depend; 2016 Mar; 160():76-81. PubMed ID: 26796595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methamphetamine use and methadone maintenance treatment: an emerging problem in the drug addiction treatment network in Iran.
    Shariatirad S; Maarefvand M; Ekhtiari H
    Int J Drug Policy; 2013 Nov; 24(6):e115-6. PubMed ID: 23773684
    [No Abstract]   [Full Text] [Related]  

  • 28. Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial.
    Morabbi MJ; Razaghi E; Moazen-Zadeh E; Safi-Aghdam H; Zarrindast MR; Vousoghi N; Akhondzadeh S
    Int Clin Psychopharmacol; 2018 Mar; 33(2):111-119. PubMed ID: 29064909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bupropion for the treatment of methamphetamine dependence.
    Elkashef AM; Rawson RA; Anderson AL; Li SH; Holmes T; Smith EV; Chiang N; Kahn R; Vocci F; Ling W; Pearce VJ; McCann M; Campbell J; Gorodetzky C; Haning W; Carlton B; Mawhinney J; Weis D
    Neuropsychopharmacology; 2008 Apr; 33(5):1162-70. PubMed ID: 17581531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atomoxetine-Associated Possible Abnormal Uterine Bleeding in an Adolescent: A Case Report.
    Açikel SB
    J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):339-340. PubMed ID: 33814545
    [No Abstract]   [Full Text] [Related]  

  • 31. The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.
    Ray LA; Bujarski S; Courtney KE; Moallem NR; Lunny K; Roche D; Leventhal AM; Shoptaw S; Heinzerling K; London ED; Miotto K
    Neuropsychopharmacology; 2015 Sep; 40(10):2347-56. PubMed ID: 25801501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. State dependent effect of transcranial direct current stimulation (tDCS) on methamphetamine craving.
    Shahbabaie A; Golesorkhi M; Zamanian B; Ebrahimpoor M; Keshvari F; Nejati V; Fregni F; Ekhtiari H
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1591-8. PubMed ID: 24825251
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impulsivity in Alcohol-Dependent Patients with and without ADHD: The Role of Atomoxetine.
    Coppola M; Mondola R
    J Psychoactive Drugs; 2018; 50(4):361-366. PubMed ID: 29877779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atomoxetine-Related Trichotillomania in a Boy with Attention-Deficit/Hyperactivity Disorder.
    Akaltun İ; Kara T
    J Child Adolesc Psychopharmacol; 2017 Dec; 27(10):923. PubMed ID: 29099621
    [No Abstract]   [Full Text] [Related]  

  • 35. Ibudilast attenuates peripheral inflammatory effects of methamphetamine in patients with methamphetamine use disorder.
    Li MJ; Briones MS; Heinzerling KG; Kalmin MM; Shoptaw SJ
    Drug Alcohol Depend; 2020 Jan; 206():107776. PubMed ID: 31812878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine in Taiwanese children and adolescents with attention-deficit/hyperactivity disorder.
    Gau SS; Huang YS; Soong WT; Chou MC; Chou WJ; Shang CY; Tseng WL; Allen AJ; Lee P
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):447-60. PubMed ID: 17822340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence.
    Johnson BA; Ait-Daoud N; Elkashef AM; Smith EV; Kahn R; Vocci F; Li SH; Bloch DA;
    Int J Neuropsychopharmacol; 2008 Feb; 11(1):1-14. PubMed ID: 17470315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of effects of ifenprodil in patients with methamphetamine dependence: Protocol for an exploratory, randomized, double-blind, placebo-controlled trial.
    Kotajima-Murakami H; Takano A; Ogai Y; Tsukamoto S; Murakami M; Funada D; Tanibuchi Y; Tachimori H; Maruo K; Sasaki T; Matsumoto T; Ikeda K
    Neuropsychopharmacol Rep; 2019 Jun; 39(2):90-99. PubMed ID: 30756527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atomoxetine effects on attentional bias to drug-related cues in cocaine dependent individuals.
    Passamonti L; Luijten M; Ziauddeen H; Coyle-Gilchrist ITS; Rittman T; Brain SAE; Regenthal R; Franken IHA; Sahakian BJ; Bullmore ET; Robbins TW; Ersche KD
    Psychopharmacology (Berl); 2017 Aug; 234(15):2289-2297. PubMed ID: 28551713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.
    Geller D; Donnelly C; Lopez F; Rubin R; Newcorn J; Sutton V; Bakken R; Paczkowski M; Kelsey D; Sumner C
    J Am Acad Child Adolesc Psychiatry; 2007 Sep; 46(9):1119-1127. PubMed ID: 17712235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.